merged_engineered-virus-steals-proteins-from-hiv.txt
<question_number>1</question_number>
<answer>TIPs may only require a single injection, while lenacapavir requires twice-yearly shots.</answer>
<question_number>2</question_number>
<answer>It might make it harder for people to transmit H.I.V. to others.</answer>
<question_number>3</question_number>
<answer>TIPs permanently integrate into the patient's DNA.</answer>
<question_number>4</question_number>
<answer>TIPs directly compete with H.I.V. for resources within cells, while protease inhibitors target viral proteins.</answer>
<question_number>5</question_number>
<answer>Unexpected side effects may be irreversible due to TIPs' integration into DNA.</answer>
<question_number>6</question_number>
<answer>TIPs are engineered to enter viral shells more effectively, leading to the production of more TIPs than H.I.V. particles.</answer>
<question_number>7</question_number>
<answer>Permanent side effects that cannot be removed.</answer>
<question_number>8</question_number>
<answer>It targets a fundamental aspect of viral replication (stealing essential proteins) that could be applicable to other viruses.</answer>
<question_number>9</question_number>
<answer>Doctors cannot obtain consent from individuals who might be indirectly infected with TIPs.</answer>
<question_number>10</question_number>
<answer>TIPs compete with H.I.V. for resources and viral shells, while protease inhibitors block the action of specific viral proteins.</answer>